The serotonergic system and cognitive function

Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer’s disease (AD). The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Švob Štrac Dubravka, Pivac Nela, Mück-Šeler Dorotea
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2016
Materias:
Acceso en línea:https://doaj.org/article/ad3ca81d39e04ec3bde098d094848ef3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ad3ca81d39e04ec3bde098d094848ef3
record_format dspace
spelling oai:doaj.org-article:ad3ca81d39e04ec3bde098d094848ef32021-12-05T14:11:04ZThe serotonergic system and cognitive function2081-693610.1515/tnsci-2016-0007https://doaj.org/article/ad3ca81d39e04ec3bde098d094848ef32016-01-01T00:00:00Zhttps://doi.org/10.1515/tnsci-2016-0007https://doaj.org/toc/2081-6936Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer’s disease (AD). The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are not completely understood. Studies have focused on serotonin (5-hydroxytryptamine, 5-HT) as one of the possible cognitionrelated biomarkers. The aim of this review is to provide a summary of the current literature on the role of the serotonergic (5-HTergic) system in cognitive function, particularly in AD and schizophrenia.Švob Štrac DubravkaPivac NelaMück-Šeler DoroteaDe Gruyterarticlealzheimer’s diseasecognitive functionreceptorsschizophreniaserotoninNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENTranslational Neuroscience, Vol 7, Iss 1, Pp 35-49 (2016)
institution DOAJ
collection DOAJ
language EN
topic alzheimer’s disease
cognitive function
receptors
schizophrenia
serotonin
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle alzheimer’s disease
cognitive function
receptors
schizophrenia
serotonin
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Švob Štrac Dubravka
Pivac Nela
Mück-Šeler Dorotea
The serotonergic system and cognitive function
description Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer’s disease (AD). The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are not completely understood. Studies have focused on serotonin (5-hydroxytryptamine, 5-HT) as one of the possible cognitionrelated biomarkers. The aim of this review is to provide a summary of the current literature on the role of the serotonergic (5-HTergic) system in cognitive function, particularly in AD and schizophrenia.
format article
author Švob Štrac Dubravka
Pivac Nela
Mück-Šeler Dorotea
author_facet Švob Štrac Dubravka
Pivac Nela
Mück-Šeler Dorotea
author_sort Švob Štrac Dubravka
title The serotonergic system and cognitive function
title_short The serotonergic system and cognitive function
title_full The serotonergic system and cognitive function
title_fullStr The serotonergic system and cognitive function
title_full_unstemmed The serotonergic system and cognitive function
title_sort serotonergic system and cognitive function
publisher De Gruyter
publishDate 2016
url https://doaj.org/article/ad3ca81d39e04ec3bde098d094848ef3
work_keys_str_mv AT svobstracdubravka theserotonergicsystemandcognitivefunction
AT pivacnela theserotonergicsystemandcognitivefunction
AT muckselerdorotea theserotonergicsystemandcognitivefunction
AT svobstracdubravka serotonergicsystemandcognitivefunction
AT pivacnela serotonergicsystemandcognitivefunction
AT muckselerdorotea serotonergicsystemandcognitivefunction
_version_ 1718371439740977152